AI in clinical trials holds great promise for the entire drug development lifecycle. However, any new technology should ...

Decentralized trials help developers of central nervous system treatments and devices address shifting regulatory barriers.

Dr. Hope Rugo and Dr. Vivek Subbiah discuss innovative trial designs to enable robust studies for smaller patient populations, as well as the promise of precision medicine, novel therapeutic ...

In order to plan and conduct pediatric clinical trials we need to address the unique ethical issues. Children require a higher standard of ethics, regulatory and developmental consideration. Since ...

From a trial design perspective, we’ve tried to make these trials as familiar to stakeholders – regulators, prescribers, payors – as possible. What’s remarkable here are the qualities of the drug that ...

Clinical trials are evolving in response to growing expectations around diversity, accessibility and patient-centricity.

Cancer is not static. It evolves, mutates, adapts, and resists. That volatility makes clinical trials a critical component of cancer treatment. Yet despite advances resulting from these studies, only ...

Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: Educational ...

Stress has often been called the psychological problem of the 21 st century. Though stress can have some advantageous effects when it comes to productivity, it can also be significantly detrimental to ...

The field of rare cancer research is rapidly transforming, marked by significant progress in clinical trials and treatment strategies. Rare cancers, as defined by the National Cancer Institute, occur ...